Zenobio Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 08-12-2024
- Paid Up Capital ₹ 2.00 M
as on 08-12-2024
- Company Age 47 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 47.96%
(FY 2022)
- Profit 56.58%
(FY 2022)
- Ebitda 34.62%
(FY 2022)
- Net Worth 21.71%
(FY 2022)
- Total Assets 22.52%
(FY 2022)
About Zenobio Life Sciences
The Corporate was formerly known as P. K. Organisers Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kevin Rajnikant, Savani Dharmesh, Mrunal Prajapati, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ1977PTC003071
- Company No.
003071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 1977
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Zenobio Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savani Dharmesh  | Director | 28-May-2012 | Current |
| Kevin Rajnikant | Director | 01-Sep-2011 | Current |
| Mrunal Prajapati | Director | 16-Jun-2015 | Current |
| Sachin Prajapati | Director | 16-Jun-2015 | Current |
Financial Performance of Zenobio Life Sciences.
Zenobio Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.96% increase. The company also saw a substantial improvement in profitability, with a 56.58% increase in profit. The company's net worth Soared by an impressive increase of 21.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenobio Life Sciences?
In 2022, Zenobio Life Sciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Advino Healthcare Private LimitedActive 8 years 6 monthsKevin Rajnikant and Savani Dharmesh are mutual person
Asilia Home Healthcare Private LimitedActive 10 years 4 monthsKevin Rajnikant and Savani Dharmesh are mutual person
Advino Technologies LlpActive 8 years 6 monthsKevin Rajnikant and Savani Dharmesh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zenobio Life Sciences?
Zenobio Life Sciences has a workforce of 17 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenobio Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenobio Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
